Skip to main content
Year archive

ONCOSIL MEDICAL LTD — 2024 filings

All 119 regulatory filings released by ONCOSIL MEDICAL LTD (OSL) in 2024, sourced directly from the official regulator.

119 Filings
2024 Period
2024 filings (119)
Filing Released Lang
First Patient in Australia Randomised in TRIPP-FFX Trial 2 pages 162.2KB
Regulatory Filings
2024-12-30 English
Change of Director's Interest Notice DC 4 pages 157.1KB
Director's Dealing
2024-12-19 English
Oncosil completes $1 million Share Purchase Plan (SPP) 2 pages 135.3KB
Capital/Financing Update
2024-12-12 English
Application for quotation of securities - OSL 6 pages 18.4KB
Share Issue/Capital Change
2024-12-12 English
Application for quotation of securities - OSL 6 pages 18.5KB
Share Issue/Capital Change
2024-12-12 English
Application for quotation of securities - OSL 6 pages 18.6KB
Share Issue/Capital Change
2024-12-12 English
OSLOC Options Range of Units and Top 20 Holders 3 pages 182.8KB
Major Shareholding Notification
2024-12-12 English
Notification regarding unquoted securities - OSL 6 pages 18.9KB
Share Issue/Capital Change
2024-12-12 English
Results of Meeting 2 pages 189.3KB
Declaration of Voting Results & Voting Rights Announcements
2024-12-10 English
Constitution 54 pages 587.1KB
Governance Information
2024-11-28 English
Application for quotation of securities - OSL 6 pages 18.4KB
Share Issue/Capital Change
2024-11-27 English
Notice under section 708A 1 page 144.6KB
Capital/Financing Update
2024-11-27 English
Proposed issue of securities - OSL 5 pages 17.2KB
Capital/Financing Update
2024-11-26 English
AGM Chairman's Address and CEO & MD Presentation 28 pages 2.9MB
AGM Information
2024-11-19 English
Results of Meeting 2 pages 190.5KB
Declaration of Voting Results & Voting Rights Announcements
2024-11-19 English
OncoSil Signs Distribution Agreements for Nordics and Egypt 2 pages 162.9KB
Capital/Financing Update
2024-11-17 English
Investor Webinar Presentation 20 pages 1.4MB
Investor Presentation
2024-11-14 English
Investor Webinar 2 pages 141.3KB
Regulatory Filings
2024-11-12 English
Notice of Extraordinary General Meeting December 2024 23 pages 555.8KB
Proxy Solicitation & Information Statement
2024-11-11 English
First OncoSil Treatment at Instituto Nazionale dei Tumori 2 pages 162.3KB
Regulatory Filings
2024-11-10 English
Prospectus 2024 Share Purchase Plan (SPP) Offer 49 pages 1.1MB
Capital/Financing Update
2024-11-05 English
Change in substantial holding from SOL 7 pages 1.4MB
Major Shareholding Notification
2024-11-05 English
Change in substantial holding from PCG 3 pages 957.6KB
Major Shareholding Notification
2024-11-04 English
Application for quotation of securities - OSL 6 pages 18.4KB
Share Issue/Capital Change
2024-10-31 English
Notice under section 708A 1 page 144.5KB
Capital/Financing Update
2024-10-31 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 504.0KB
Interim / Quarterly Report
2024-10-30 English
Amended Share Purchase Plan (SPP) Timetable 2 pages 158.0KB
Capital/Financing Update
2024-10-29 English
OncoSil Appoints Rachel Duggan as EMEA Sales Director 2 pages 143.2KB
Board/Management Information
2024-10-28 English
Update - Proposed issue of securities - OSL 8 pages 27.0KB
Capital/Financing Update
2024-10-28 English
OSL completes $7 M Placement and announces $1 M SPP 6 pages 236.7KB
Capital/Financing Update
2024-10-27 English
Proposed issue of securities - OSL 5 pages 18.1KB
Capital/Financing Update
2024-10-27 English
Proposed issue of securities - OSL 6 pages 22.0KB
Capital/Financing Update
2024-10-27 English
Capital Raise Presentation 34 pages 2.4MB
Capital/Financing Update
2024-10-27 English
Proposed issue of securities - OSL 8 pages 27.2KB
Capital/Financing Update
2024-10-27 English
Trading Halt 2 pages 537.0KB
Capital/Financing Update
2024-10-23 English
G-BA Approval received for OncoSil Device 3 pages 126.1KB
Regulatory Filings
2024-10-23 English
Notice of Annual General Meeting 25 pages 701.3KB
AGM Information
2024-10-21 English
OncoSil Medical Limited Receives UKCA Renewal Certificates 2 pages 135.1KB
Regulatory Filings
2024-10-20 English
OncoSil signs distribution agreement with Al Zahrawi Medical 2 pages 162.1KB
Regulatory Filings
2024-10-06 English
Application for quotation of securities - OSL 6 pages 18.2KB
Share Issue/Capital Change
2024-10-01 English
Peter Hall elects not to join OncoSil Board 1 page
Board/Management Information
2024-09-29 English
Annual Report 63 pages 776.1KB
Annual Report
2024-09-29 English
Annual Report Differences to Appendix 4E 3 pages 257.0KB
Capital/Financing Update
2024-09-29 English
Corporate Governance Statement and Appendix 4G 20 pages 530.0KB
Governance Information
2024-09-29 English
50% Recruitment in TRIPP-FFX and PANCOSIL Clinical Trials 2 pages 165.1KB
Regulatory Filings
2024-09-25 English
Comparative Analysis Indicates Benefits from OncoSil 2 pages 171.5KB
Regulatory Filings
2024-09-17 English
Results of Meeting 2 pages 239.4KB
Declaration of Voting Results & Voting Rights Announcements
2024-09-17 English
Application for quotation of securities - OSL 6 pages 18.3KB
Share Issue/Capital Change
2024-09-17 English
Strong Market Penetration with 30th OncoSil Treatment 2 pages 163.4KB
Capital/Financing Update
2024-09-12 English
Appendix 4E Preliminary Financial Report 17 pages 229.7KB
Annual Report
2024-08-29 English
Appointment of Peter Hall as Non-Executive Director 2 pages 135.2KB
Board/Management Information
2024-08-29 English
Notice of Extraordinary General Meeting/Proxy Form 12 pages 477.2KB
Proxy Solicitation & Information Statement
2024-08-19 English
Successful Treatment with OncoSil Device in Turkiye 2 pages 163.5KB
Regulatory Filings
2024-08-14 English
Significant Growth in Commercial Treatment Sales in Q4 FY24 2 pages 163.0KB
Capital/Financing Update
2024-08-14 English
Ceasing to be a substantial holder SC 2 pages 128.5KB
Major Shareholding Notification
2024-08-13 English
Application for quotation of securities - OSL 6 pages 18.5KB
Share Issue/Capital Change
2024-08-06 English
Prospectus 32 pages 531.9KB
Capital/Financing Update
2024-08-06 English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 782.8KB
Interim / Quarterly Report
2024-07-30 English
Notice of Initial Substantial Holding from SOL 7 pages 473.2KB
Major Shareholding Notification
2024-07-30 English
Becoming a substantial holder from PCG 3 pages 425.0KB
Major Shareholding Notification
2024-07-29 English
Application for quotation of securities - OSL 6 pages 18.6KB
Share Issue/Capital Change
2024-07-28 English
Notice under section 708A 2 pages 162.6KB
Capital/Financing Update
2024-07-28 English
Australian institution to invest $2.7 million in OSL 2 pages 173.3KB
Capital/Financing Update
2024-07-24 English
Proposed issue of securities - OSL 5 pages 19.4KB
Capital/Financing Update
2024-07-24 English
Proposed issue of securities - OSL 5 pages 17.4KB
Capital/Financing Update
2024-07-24 English
Investor Presentation 22 pages 3.2MB
Investor Presentation
2024-07-22 English
Director Appointment/Resignation PH 2 pages 132.1KB
Board/Management Information
2024-07-14 English
Peter Hall to be appointed Non-Executive Director (addendum) 2 pages 134.5KB
Board/Management Information
2024-07-14 English
Letter to Short Dated Option Holders 1 page 81.0KB
Regulatory Filings
2024-07-11 English
Application for quotation of securities - OSL 7 pages 22.1KB
Share Issue/Capital Change
2024-07-09 English
OSL Short Dated Options Range of Units and Top 20 Holders 3 pages 182.0KB
Major Shareholding Notification
2024-07-09 English
Application for quotation of securities - OSL 6 pages 19.9KB
Regulatory Filings
2024-07-02 English
Notification regarding unquoted securities - OSL 5 pages 17.0KB
Share Issue/Capital Change
2024-07-02 English
Notification regarding unquoted securities - OSL 5 pages 16.9KB
Share Issue/Capital Change
2024-06-23 English
Proposed issue of securities - OSL 5 pages 17.0KB
Capital/Financing Update
2024-06-20 English
5th patient is treated in PANCOSIL trial 2 pages 138.3KB
Regulatory Filings
2024-06-10 English
200th patient treated with the OncoSil device 2 pages 191.2KB
Regulatory Filings
2024-06-02 English
OncoSil signs distribution agreement for Saudi Arabia 3 pages 199.5KB
Regulatory Filings
2024-05-22 English
Application for quotation of securities - OSL 7 pages 21.3KB
Regulatory Filings
2024-05-19 English
Notification regarding unquoted securities - OSL 5 pages 16.9KB
Share Issue/Capital Change
2024-05-19 English
Change in substantial holding 3 pages 101.9KB
Regulatory Filings
2024-05-19 English
Results of Meeting 2 pages 201.4KB
Declaration of Voting Results & Voting Rights Announcements
2024-05-14 English
Application for quotation of securities - OSL 6 pages 20.0KB
Share Issue/Capital Change
2024-05-14 English
Notification regarding unquoted securities - OSL 5 pages 17.3KB
Share Issue/Capital Change
2024-05-14 English
Application for quotation of securities - OSL 6 pages 20.0KB
Share Issue/Capital Change
2024-05-09 English
Notification regarding unquoted securities - OSL 5 pages 17.2KB
Share Issue/Capital Change
2024-05-09 English
Application for quotation of securities - OSL 6 pages 20.0KB
Regulatory Filings
2024-05-07 English
Notification regarding unquoted securities - OSL 5 pages 17.3KB
Share Issue/Capital Change
2024-05-07 English
Application for quotation of securities - OSL 6 pages 19.9KB
Share Issue/Capital Change
2024-05-02 English
Notification regarding unquoted securities - OSL 5 pages 17.2KB
Share Issue/Capital Change
2024-05-02 English
$5.3 million raised under Entitlement Offer 2 pages 178.5KB
Capital/Financing Update
2024-05-01 English
Application for quotation of securities - OSL 6 pages 19.8KB
Share Issue/Capital Change
2024-05-01 English
Notification regarding unquoted securities - OSL 5 pages 17.2KB
Share Issue/Capital Change
2024-05-01 English
1st Study in Man Increases Pancreatic Tumor Vascularity 3 pages 200.3KB
Regulatory Filings
2024-04-30 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 471.2KB
Interim / Quarterly Report
2024-04-29 English
Two more PANCOSIL Trial treatments using OncoSil device 2 pages 166.2KB
Regulatory Filings
2024-04-16 English
Notice of Extraordinary General Meeting/Proxy Form 19 pages 511.7KB
Proxy Solicitation & Information Statement
2024-04-15 English
First patient treated with OncoSil device in Turkiye 2 pages 219.0KB
Regulatory Filings
2024-04-15 English
First patient treated in the UK for the TRIPP-FXX study 3 pages 270.3KB
Regulatory Filings
2024-04-11 English
UK Private Insurer Approves Reimbursement for OncoSil 2 pages 201.6KB
Capital/Financing Update
2024-04-08 English
First Austria-based treatments utilising the OncoSil device 3 pages 384.1KB
Regulatory Filings
2024-04-04 English
Dispatch of Entitlement Offer Prospectus 4 pages 268.6KB
Capital/Financing Update
2024-04-03 English
Application for quotation of securities - OSL 6 pages 18.4KB
Share Issue/Capital Change
2024-03-27 English
Notice under section 708A 2 pages 162.3KB
Capital/Financing Update
2024-03-27 English
Prospectus - Entitlement Offer 50 pages 975.1KB
Capital/Financing Update
2024-03-24 English
Update - Proposed issue of securities - OSL 9 pages 31.1KB
Capital/Financing Update
2024-03-21 English
Placement and Entitlement Offer - amended timetable 2 pages 145.5KB
Capital/Financing Update
2024-03-21 English
Update - Proposed issue of securities - OSL 9 pages 30.7KB
Capital/Financing Update
2024-03-21 English
Placement and Entitlement Offer - addendum 2 pages 194.6KB
Capital/Financing Update
2024-03-20 English
Placement and Entitlement Offer to raise up to $7.1 million 5 pages 245.7KB
Capital/Financing Update
2024-03-19 English
Proposed issue of securities - OSL 5 pages 17.8KB
Capital/Financing Update
2024-03-19 English
Proposed issue of securities - OSL 6 pages 22.6KB
Capital/Financing Update
2024-03-19 English
Proposed issue of securities - OSL 9 pages 31.8KB
Capital/Financing Update
2024-03-19 English
Investor Presentation 32 pages 2.8MB
Investor Presentation
2024-03-19 English
Trading Halt 2 pages 199.7KB
Capital/Financing Update
2024-03-17 English
Appendix 4D and Half Year Accounts 26 pages 689.8KB
Interim / Quarterly Report
2024-02-27 English
84 German hospitals can negotiate fee for Oncosil device 2 pages 202.0KB
Regulatory Filings
2024-01-31 English
OncoSil signs distribution agreement for Turkish market 3 pages 242.9KB
Regulatory Filings
2024-01-31 English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 515.5KB
Interim / Quarterly Report
2024-01-30 English